Axogen, Inc. Increase (Decrease) in Contract with Customer, Liability
Axogen, Inc. (AXGN) reported Increase (Decrease) in Contract with Customer, Liability of $424.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2025-02-26
- Axogen, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was $0.00.
- Axogen, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-12-31 was $0.00.
- Axogen, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-09-30 was $0.00.
- Axogen, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2022-06-30 was $0.00.
- Axogen, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was $424.00K.
- Axogen, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$14.00K.
- Axogen, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was $0.00.
- Axogen, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was -$3.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $424.00K 10-K · filed 2025-02-26 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$14.00K 10-K · filed 2025-02-26 | ||
| 2023-09-30 | -$14.00K 10-Q · filed 2023-11-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | -$2.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | -$2.00K derived: sum of 3 quarters · filed 2024-03-05 | -$3.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.00K derived: sum of 2 quarters · filed 2022-11-08 | -$3.00K 10-Q · filed 2022-11-08 | -$6.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$3.00K 10-Q · filed 2022-08-05 | -$6.00K derived: sum of 3 quarters · filed 2023-03-14 | -$9.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | -$1.00K 10-Q · filed 2022-05-05 | -$4.00K derived: sum of 2 quarters · filed 2023-03-14 | -$7.00K derived: sum of 3 quarters · filed 2023-03-14 | -$10.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$6.00K derived: sum of 2 quarters · filed 2023-03-14 | -$9.00K derived: sum of 3 quarters · filed 2023-03-14 | -$12.00K 10-K · filed 2023-03-14 |
| 2020-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$6.00K derived: sum of 2 quarters · filed 2021-11-04 | -$9.00K 10-Q · filed 2021-11-04 | -$16.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$6.00K 10-Q · filed 2021-08-05 | -$13.00K derived: sum of 3 quarters · filed 2022-02-25 | -$24.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$3.00K 10-Q · filed 2021-05-06 | -$10.00K derived: sum of 2 quarters · filed 2022-02-25 | -$21.00K derived: sum of 3 quarters · filed 2022-02-25 | -$31.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$18.00K derived: sum of 2 quarters · filed 2022-02-25 | -$28.00K derived: sum of 3 quarters · filed 2022-02-25 | -$30.00K 10-K · filed 2022-02-25 |
| 2019-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$21.00K derived: sum of 2 quarters · filed 2020-10-30 | -$23.00K 10-Q · filed 2020-10-30 | -$41.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$12.00K 10-Q · filed 2020-08-07 | -$30.00K derived: sum of 3 quarters · filed 2021-03-01 | -$47.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$2.00K 10-Q · filed 2020-05-06 | -$20.00K derived: sum of 2 quarters · filed 2021-03-01 | -$37.00K derived: sum of 3 quarters · filed 2021-03-01 | -$55.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$35.00K derived: sum of 2 quarters · filed 2021-03-01 | -$53.00K derived: sum of 3 quarters · filed 2021-03-01 | -$66.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$35.00K derived: sum of 2 quarters · filed 2019-11-06 | -$48.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$31.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$13.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $70.00K 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $18.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |